Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Papillomavirus Infections 2Neuroblastoma 2Lymphoma, Large B-Cell, Diffuse 2Hemangiosarcoma 2HIV Infections 2Ependymoma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Anus Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thromboembolism 1Thrombocythemia, Essential 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1

Interventions

Temozolomide 4Watchful Waiting 2Vincristine 2Filgrastim 2Etoposide 2Cyclophosphamide 2Cisplatin 2veliparib 1omburtamab I-131 1lonafarnib 1imetelstat 1Triiodothyronine 1Radiotherapy, Conformal 1Radiotherapy 1Potassium Iodide 1Platinum 1Observation 1Mesna 1Irinotecan 1Histamine Antagonists 1Granulocyte Colony-Stimulating Factor 1GRN163L peptide 1Dexamethasone 1Chemotherapy, Adjuvant 1Carboplatin 1Bevacizumab 1Antipyretics 1Antiemetics 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Ependymoma × Watchful Waiting × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

NCT05259605 2025-12-17

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

European Organisation for Research and Treatment of Cancer - EORTC

Recruiting
1,650 enrolled
CNS

Ependymoma, Glioma, Hemangiopericytoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Choroid Plexus Neoplasms, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡